Denmark has destroyed more than 145,000 kilograms of cannabis
Much of the medical cannabis produced under Denmark’s regulatory regime has never made it to market and was intentionally destroyed for various reasons, according to government data.
UK committee calls for wider access to ‘unlicensed’ medical cannabis
The United Kingdom’s Home Affairs Committee is recommending the government widen access to unlicensed cannabis-based products for medical use via the National Health Service before the end of the current Parliament.
Somai wins EU-GMP certification for Portugal cannabis facility
Somai Pharmaceuticals said it received European Union-Good Manufacturing Practice (EU-GMP) certification from the Portuguese health authority Infarmed.
Australia, Israel top destinations of Canadian medical cannabis exports
Australia and Israel were the top markets for Canada’s medical cannabis exporters last year, as the quantity of flower shipped overseas continued to surge, according to new figures shared by Health Canada with MJBizDaily.
Canadian cannabis exports surge 50% to CA$160 million in 2022-23
Amid declining medical cannabis sales in Canada’s domestic market and cutthroat competition in the adult-use industry, some licensed producers are increasingly looking to overseas markets for a financial lifeline.
Organigram secures United Kingdom cannabis supply deal
Canadian licensed producer Organigram Holdings has struck a supply agreement with 4C Labs to provide dried medical cannabis flower for the United Kingdom market.
Germany’s cannabis insurance payouts hit 51 million euros in first quarter
Insurance reimbursements for medical cannabinoid products in Germany continued to grow in the first quarter of 2023, showing that Europe’s largest economy continues to see a gradual expansion of its cannabis industry – now one of the largest in the world.
